CARL

$15.8910.35%1.49

Carlsmed Inc (CARL)

Date: O: H: L: C: Vol:

Precedente Chiudi:

$14.40

Aprire:

$14.77

Volume 24 ore:

32,366

Volume relativo:

0.33

Capitalizzazione di mercato:

$433.84M

Reddito:

$56.44M

Utile/perdita netta:

-$32.60M

Rapporto P/E:

EPS:

-$1.23

Flusso di cassa netto:

-$35.15M

1W Prestazione:

+3.79%

1M Prestazione:

+11.35%

6M Prestazione:

+74.81%

1Y Prestazione:

+28.56%

Intervallo 1D:

$14.77$16.08

Intervallo di 1 settimana:

$14.27$16.13

Portata 52W:

$8.50$17.23

Profilo aziendale di Carlsmed Inc (CARL)

Nome

Carlsmed Inc

Settore

Healthcare

Industria

Health Information Services

Telefono

858-295-9290

Indirizzo

1800 ASTON AVENUE, CARLSBAD, USA

Dipendente

127

Prossima data di guadagno

2026-11-10

Ultimi documenti SEC

SEC

Discussioni di CARL su X

Cap. di mercato

Reddito

Reddito netto

Flusso di cassa

EPS

Carlsmed Inc Azioni (CARL) Upgrade e downgrade

Data	Azione	Analista	Modifica della valutazione
2026-07-01	Iniziato	Needham	Buy
2025-08-18	Iniziato	BTIG Research	Buy
2025-08-18	Iniziato	BofA Securities	Buy
2025-08-18	Iniziato	Goldman	Buy
2025-08-18	Iniziato	Piper Sandler	Overweight
2025-08-18	Iniziato	Truist	Buy

Carlsmed Inc Azioni (CARL) Dati Finanziari

Periodo	Andamento	FY 2025
Data di fine periodo		2025-12-31
Revenue USD (M)		50.51
Cost of revenue USD (M)		12.47
Gross profit USD (M)		38.04
Research and development USD (M)		17.02
Operating expenses USD (M)		68.61
Operating income USD (M)		-30.57
Income tax expense USD (M)		0.00
Net income USD (M)		-29.63
Basic EPS USD/shares		-2.12
Diluted EPS USD/shares		-2.12
Basic weighted shares shares (M)		14.22
Diluted weighted shares shares (M)		14.22

Carlsmed Inc Azioni (CARL) insider trading

Bertolini JeffreyNov 03 '26
Officer
Transazione
Proposed Sale
Costo
$15.15
#Azioni
747
Valore ($)
11,317
#Azioni Totale
0
Bertolini JeffreyOct 30 '26
Chief Operating Officer
Transazione
Option Exercise
Costo
$2.23
#Azioni
243
Valore ($)
542
#Azioni Totale
22,732
Bertolini JeffreyOct 30 '26
Chief Operating Officer
Transazione
Sale
Costo
$15.80
#Azioni
243
Valore ($)
3,839
#Azioni Totale
22,489
Bertolini JeffreyOct 30 '26
Officer
Transazione
Proposed Sale
Costo
$15.80
#Azioni
243
Valore ($)
3,839
#Azioni Totale
0
Greenstein Leonard M.Oct 14 '26
Former Officer
Transazione
Proposed Sale
Costo
$13.99
#Azioni
4,136
Valore ($)
57,872
#Azioni Totale
0
Bertolini JeffreyOct 05 '26
Officer
Transazione
Proposed Sale
Costo
$14.39
#Azioni
747
Valore ($)
10,749
#Azioni Totale
0
Bertolini JeffreyOct 05 '26
Chief Operating Officer
Transazione
Option Exercise
Costo
$5.92
#Azioni
747
Valore ($)
4,419
#Azioni Totale
23,236
Bertolini JeffreyOct 05 '26
Chief Operating Officer
Transazione
Sale
Costo
$14.39
#Azioni
747
Valore ($)
10,749
#Azioni Totale
22,489
Bertolini JeffreySep 30 '26
Chief Operating Officer
Transazione
Option Exercise
Costo
$2.23
#Azioni
243
Valore ($)
542
#Azioni Totale
22,732
Bertolini JeffreySep 30 '26
Chief Operating Officer
Transazione
Sale
Costo
$13.99
#Azioni
243
Valore ($)
3,400
#Azioni Totale
22,489

Commercio interno	Relazione	Data	Transazione	Costo	#Azioni	Valore ($)	#Azioni Totale
Bertolini Jeffrey	Officer	Nov 03 '26	Proposed Sale	$15.15	747	11,317	0
Bertolini Jeffrey	Chief Operating Officer	Oct 30 '26	Option Exercise	$2.23	243	542	22,732
Bertolini Jeffrey	Chief Operating Officer	Oct 30 '26	Sale	$15.80	243	3,839	22,489
Bertolini Jeffrey	Officer	Oct 30 '26	Proposed Sale	$15.80	243	3,839	0
Greenstein Leonard M.	Former Officer	Oct 14 '26	Proposed Sale	$13.99	4,136	57,872	0
Bertolini Jeffrey	Officer	Oct 05 '26	Proposed Sale	$14.39	747	10,749	0
Bertolini Jeffrey	Chief Operating Officer	Oct 05 '26	Option Exercise	$5.92	747	4,419	23,236
Bertolini Jeffrey	Chief Operating Officer	Oct 05 '26	Sale	$14.39	747	10,749	22,489
Bertolini Jeffrey	Chief Operating Officer	Sep 30 '26	Option Exercise	$2.23	243	542	22,732
Bertolini Jeffrey	Chief Operating Officer	Sep 30 '26	Sale	$13.99	243	3,400	22,489

Carlsmed Inc Borsa (CARL) Ultime notizie

Oct 14, 2026

Carlsmed Launches aprevo® Lumbar Bi-lateral Posterior System - GlobeNewswire Inc.

Oct 14, 2026

Oct 07, 2026

Form 4 Carlsmed Inc For: 7 October By Investing.com - Investing.com Nigeria

Oct 07, 2026

Oct 06, 2026

After exercising options, Carlsmed (CARL)'s COO sells 747 shares at $14.39. - Stock Titan

Oct 06, 2026

Oct 05, 2026

Carlsmed Officer Jeffrey Bertolini Files Form 144 to Sell 747 Shares Acquired via Stock Option - Kalkine Media

Oct 05, 2026

Oct 02, 2026

Carlsmed, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

Oct 02, 2026

Form 4 Carlsmed Inc For: 2 October By Investing.com - Investing.com South Africa

Oct 02, 2026

Form 4 Carlsmed Inc For: 2 October By Investing.com - Investing.com Canada

Oct 02, 2026

Oct 01, 2026

At $13.99 a share, Carlsmed (CARL) COO sells 243 shares under a prearranged trading plan. - Stock Titan

Oct 01, 2026

Sep 30, 2026

Form 4 Carlsmed Inc For: 30 September By Investing.com - Investing.com South Africa

Sep 30, 2026

Form 4 Carlsmed Inc For: 30 September By Investing.com - Investing.com UK

Sep 30, 2026

Stock awards for Carlsmed (CARL)'s CFO include 89,286 units and options exercisable at $14.18. - Stock Titan

Sep 30, 2026

Carlsmed (CARL) legal chief holds options on 90,000 shares alongside 56,222 common shares. - Stock Titan

Sep 30, 2026

Sep 16, 2026

Presidio Management Group XII buys $3m in Carlsmed stock By Investing.com - Investing.com India

Sep 16, 2026

Presidio Management Group XII buys $3m in Carlsmed stock By Investing.com - Investing.com Canada

Sep 16, 2026

Presidio Management Group XII buys $3m in Carlsmed stock - Investing.com

Sep 16, 2026

Sep 15, 2026

Ten percent owner boosts stake in Carlsmed (CARL) - Stock Titan

Sep 15, 2026

Sep 10, 2026

Carlsmed COO Jeffrey Bertolini Awarded 50,000 Stock Options with $15.23 Exercise Price - Kalkine Media

Sep 10, 2026

Carlsmed (CARL) awards COO 50,000 stock options - Stock Titan

Sep 10, 2026

Carlsmed (CARL) COO discloses 22,489-share stake - Stock Titan

Sep 10, 2026

Sep 09, 2026

Carlsmed, Inc.: Shareholders Board Members Managers and Company Profile | US14280C1053 - marketscreener.com

Sep 09, 2026

Sep 08, 2026

Carlsmed, Inc. Announces Chief Operating Officer Appointment - marketscreener.com

Sep 08, 2026

Carlsmed, Inc. Announces Chief Operating Officer Appointment - Yahoo Finance

Sep 08, 2026

symbol__ Stock Quote Price and Forecast - cnn.com

Sep 08, 2026

Sep 06, 2026

BlackRock Inc. Purchases New Holdings in Carlsmed, Inc. $CARL - MarketBeat

Sep 06, 2026

Aug 30, 2026

Jupiter Topco LLC Acquires New Holdings in Carlsmed, Inc. $CARL - MarketBeat

Aug 30, 2026

Aug 25, 2026

Wall Street Analysts Think Carlsmed, Inc. (CARL) Could Surge 90.77%: Read This Before Placing a Bet - qz.com

Aug 25, 2026

Parkman Healthcare Partners LLC Invests $6.20 Million in Carlsmed, Inc. $CARL - MarketBeat

Aug 25, 2026

Aug 24, 2026

Carlsmed (CARL) Earnings Snapshot: EPS Lands Above Forecast on the Day; The Stock Ends Down 1.56% in the Current Update - Dividend Growth Analysis - dars.gov.et

Aug 24, 2026

Aug 21, 2026

Carlsmed, Inc. (NASDAQ:CARL) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat

Aug 21, 2026

Aug 15, 2026

Wall Street Zen Upgrades Carlsmed (NASDAQ:CARL) to "Hold" - MarketBeat

Aug 15, 2026

Aug 14, 2026

Carlsmed (CARL) plans up to $250M in stock, debt and warrant sales - Stock Titan

Aug 14, 2026

Aug 13, 2026

Carlsmed (CARL) Holds Steady Near $13.72 as Tight Range Signals Potential Move - Defined Outcome ETF - vinanet.vn

Aug 13, 2026

Carlsmed (CARL) Holds Steady Near $13.72 as Tight Range Signals Potential Move - Bearish Sentiment - dars.gov.et

Aug 13, 2026

Aug 12, 2026

Carlsmed Eyes Growth as Cervical Launch, Medicare Shift Boost Spine Platform - TradingView

Aug 12, 2026

Carlsmed Eyes Growth as Cervical Launch, Medicare Shift Boost Spine Platform - TradingView

Aug 12, 2026

Transcript : Carlsmed, Inc. Presents at Bank of America SMID Cap Virtual Conference, Aug-12-2026 11 - marketscreener.com

Aug 12, 2026

CARL: Personalized AI spine surgery platform accelerates growth with new reimbursement and strong clinical data - TradingView

Aug 12, 2026

CARL Q2 2026 Earnings: Narrower-Than-Expected Loss but Shares Slip 2.55% - Tax Rate Impact - vinanet.vn

Aug 12, 2026

Aug 07, 2026

Carlsmed, Inc. Common Stock (NASDAQ: CARL) Share Price, CARL Stock News, CARL Share Price & Updates - kalkine.ca

Aug 07, 2026

Carlsmed, Inc. Common Stock (NASDAQ: CARL) Share Price, CARL Stock News, CARL Share Price & Updates - Kalkine

Aug 07, 2026

Truist raises Carlsmed stock price target on strong growth outlook By Investing.com - Investing.com South Africa

Aug 07, 2026

Carlsmed Buy Rating Reaffirmed as 2026 Outlook Raised and Adoption Grows; $17 Price Target Maintained - TipRanks

Aug 07, 2026

Analysts Are Bullish on These NA Stocks: BillionToOne, Inc. Class A (BLLN), Carlsmed, Inc. (CARL) - theglobeandmail.com

Aug 07, 2026

Aug 06, 2026

Carlsmed Q2 2026 revenue up 57% to USD 18.9M - Medical Buyer

Aug 06, 2026

Truist raises Carlsmed stock price target on strong growth outlook - Investing.com Nigeria

Aug 06, 2026

CARLSMED INC Q2 NET INCOME USD -10.5 MILLION - Moomoo

Aug 06, 2026

Truist raises Carlsmed stock price target on strong growth outlook - Investing.com

Aug 06, 2026

Simile a CARL

Carlsmed Inc (CARL)

Profilo aziendale di Carlsmed Inc (CARL)

Cap. di mercato

Reddito

Reddito netto

Flusso di cassa

EPS

Carlsmed Inc Azioni (CARL) Upgrade e downgrade

Carlsmed Inc Azioni (CARL) Dati Finanziari

Carlsmed Inc Azioni (CARL) insider trading

Carlsmed Inc Borsa (CARL) Ultime notizie

Carlsmed Launches aprevo® Lumbar Bi-lateral Posterior System - GlobeNewswire Inc.

Form 4 Carlsmed Inc For: 7 October By Investing.com - Investing.com Nigeria

After exercising options, Carlsmed (CARL)'s COO sells 747 shares at $14.39. - Stock Titan

Carlsmed Officer Jeffrey Bertolini Files Form 144 to Sell 747 Shares Acquired via Stock Option - Kalkine Media

Carlsmed, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

Form 4 Carlsmed Inc For: 2 October By Investing.com - Investing.com South Africa

Form 4 Carlsmed Inc For: 2 October By Investing.com - Investing.com Canada

At $13.99 a share, Carlsmed (CARL) COO sells 243 shares under a prearranged trading plan. - Stock Titan

Form 4 Carlsmed Inc For: 30 September By Investing.com - Investing.com South Africa

Form 4 Carlsmed Inc For: 30 September By Investing.com - Investing.com UK

Stock awards for Carlsmed (CARL)'s CFO include 89,286 units and options exercisable at $14.18. - Stock Titan

Carlsmed (CARL) legal chief holds options on 90,000 shares alongside 56,222 common shares. - Stock Titan

Presidio Management Group XII buys $3m in Carlsmed stock By Investing.com - Investing.com India

Presidio Management Group XII buys $3m in Carlsmed stock By Investing.com - Investing.com Canada

Presidio Management Group XII buys $3m in Carlsmed stock - Investing.com

Ten percent owner boosts stake in Carlsmed (CARL) - Stock Titan

Carlsmed COO Jeffrey Bertolini Awarded 50,000 Stock Options with $15.23 Exercise Price - Kalkine Media

Carlsmed (CARL) awards COO 50,000 stock options - Stock Titan

Carlsmed (CARL) COO discloses 22,489-share stake - Stock Titan

Carlsmed, Inc.: Shareholders Board Members Managers and Company Profile | US14280C1053 - marketscreener.com

Carlsmed appoints Jeff Bertolini as new COO - TipRanks

Carlsmed, Inc. Announces Chief Operating Officer Appointment - The Manila Times

Carlsmed names Jeffrey Bertolini as Chief Operating Officer - TradingView

Carlsmed, Inc. Announces Chief Operating Officer Appointment - marketscreener.com

Carlsmed, Inc. Announces Chief Operating Officer Appointment - Yahoo Finance

symbol__ Stock Quote Price and Forecast - cnn.com

BlackRock Inc. Purchases New Holdings in Carlsmed, Inc. $CARL - MarketBeat

Jupiter Topco LLC Acquires New Holdings in Carlsmed, Inc. $CARL - MarketBeat

Wall Street Analysts Think Carlsmed, Inc. (CARL) Could Surge 90.77%: Read This Before Placing a Bet - qz.com

Parkman Healthcare Partners LLC Invests $6.20 Million in Carlsmed, Inc. $CARL - MarketBeat

Carlsmed (CARL) Earnings Snapshot: EPS Lands Above Forecast on the Day; The Stock Ends Down 1.56% in the Current Update - Dividend Growth Analysis - dars.gov.et

Carlsmed, Inc. (NASDAQ:CARL) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat

Wall Street Zen Upgrades Carlsmed (NASDAQ:CARL) to "Hold" - MarketBeat

Carlsmed (CARL) plans up to $250M in stock, debt and warrant sales - Stock Titan

Carlsmed (CARL) Holds Steady Near $13.72 as Tight Range Signals Potential Move - Defined Outcome ETF - vinanet.vn

Carlsmed (CARL) Holds Steady Near $13.72 as Tight Range Signals Potential Move - Bearish Sentiment - dars.gov.et

Carlsmed Eyes Growth as Cervical Launch, Medicare Shift Boost Spine Platform - TradingView

Carlsmed Eyes Growth as Cervical Launch, Medicare Shift Boost Spine Platform - TradingView

Transcript : Carlsmed, Inc. Presents at Bank of America SMID Cap Virtual Conference, Aug-12-2026 11 - marketscreener.com

CARL: Personalized AI spine surgery platform accelerates growth with new reimbursement and strong clinical data - TradingView

CARL Q2 2026 Earnings: Narrower-Than-Expected Loss but Shares Slip 2.55% - Tax Rate Impact - vinanet.vn

Carlsmed, Inc. Common Stock (NASDAQ: CARL) Share Price, CARL Stock News, CARL Share Price & Updates - kalkine.ca

Carlsmed, Inc. Common Stock (NASDAQ: CARL) Share Price, CARL Stock News, CARL Share Price & Updates - Kalkine

Truist raises Carlsmed stock price target on strong growth outlook By Investing.com - Investing.com South Africa

Carlsmed Buy Rating Reaffirmed as 2026 Outlook Raised and Adoption Grows; $17 Price Target Maintained - TipRanks

Analysts Are Bullish on These NA Stocks: BillionToOne, Inc. Class A (BLLN), Carlsmed, Inc. (CARL) - theglobeandmail.com

Carlsmed Q2 2026 revenue up 57% to USD 18.9M - Medical Buyer

Truist raises Carlsmed stock price target on strong growth outlook - Investing.com Nigeria

CARLSMED INC Q2 NET INCOME USD -10.5 MILLION - Moomoo

Truist raises Carlsmed stock price target on strong growth outlook - Investing.com

Simile a CARL